Why is Indrayani Biotec falling/rising?

As of 11-Sep, Indrayani Biotech Ltd's stock price is currently at 12.23, reflecting a decrease of 0.18, or 1.45%. The stock has shown a trend reversal, falling after two consecutive days of gains. Although the stock's performance today is inline with the sector, it has significantly underperformed in the longer term, with a year-to-date decline of 66.38% and a one-year return of -73.98%. The company has reported negative results for the last five consecutive quarters, with a substantial drop in operating profits and a high debt to EBITDA ratio, indicating weak long-term fundamental strength. Additionally, there has been a decrease in institutional investor participation, which may further contribute to the stock's downward pressure.
In the broader market context, the stock's short-term performance has been lackluster compared to the benchmark, with a one-week return of -0.49% against the Sensex's gain of 1.03%. This consistent underperformance over the past three years, coupled with a significant decline in profitability, suggests that investor confidence is waning. The stock's liquidity appears adequate for trading, but the overall negative sentiment surrounding its financial health and declining institutional interest may be driving the stock's price lower.